Journal article

Publication year: 2010

Pages: 574-577

Journal: The Journal of Heart and Lung Transplantation

Volume number: 29

Issue number: 5

ISSN: 1053-2498

eISSN: 1557-3117

DOI Link: https://doi.org/10.1016/j.healun.2009.10.006

Publisher: Elsevier

Abstract: 
Novel surgical strategies have dramatically improved the initial outcome of newborns with hypoplastic left heart syndrome. However, the single systemic right ventricle remains a major challenge, with limited effectiveness of pharmacologic therapy. The present case documents that the intracoronary administration of autologous bone marrow-derived progenitor cells is technically feasible in a critically ill infant with hypoplastic left heart syndrome and severe heart failure after a hybrid comprehensive stage II procedure. Cell therapy might represent an option before heart transplantation in children with single ventricle physiology presenting with severe heart failure. J Heart Lung Transplant 2010;29:574-577 (C) 2010 International Society for Heart and Lung Transplantation. All rights reserved.

Harvard Citation style: Rupp, S., Zeiher, A., Dimmeler, S., Tonn, T., Bauer, J., Jux, C., et al. (2010) A regenerative strategy for heart failure in hypoplastic Left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells, The Journal of Heart and Lung Transplantation, 29(5), pp. 574-577. https://doi.org/10.1016/j.healun.2009.10.006

APA Citation style: Rupp, S., Zeiher, A., Dimmeler, S., Tonn, T., Bauer, J., Jux, C., Akintuerk, H., & Schranz, D. (2010). A regenerative strategy for heart failure in hypoplastic Left heart syndrome: Intracoronary administration of autologous bone marrow-derived progenitor cells. The Journal of Heart and Lung Transplantation. 29(5), 574-577. https://doi.org/10.1016/j.healun.2009.10.006